L49.5
Exfoliation due to erythematous condition involving 50-59 percent of body surface
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 code L49.5 refers to a condition characterized by significant skin exfoliation caused by an erythematous (red and inflamed) skin condition affecting between 50% and 59% of the body surface. This condition involves the shedding or peeling of the outer skin layer, which can be a response to various underlying health issues. Understanding this condition includes its causes, symptoms, ways it is diagnosed, and potential treatments.
Causes & Symptoms
Clinical Causes: Severe drug reactions such as Stevens-Johnson syndrome or toxic epidermal necrolysis Severe sunburn or sun poisoning Infections that cause extensive skin involvement Autoimmune skin conditions like psoriasis or pemphigus Chemical or physical skin injuries Certain systemic diseases that trigger widespread skin inflammation
Key Symptoms: Extensive skin peeling or shedding, primarily on the red, inflamed areas Redness and swelling of affected skin regions Pain or soreness in the skin areas that are peeling Possible blistering or infections on the exposed skin Fever or general malaise in severe cases Itching or burning sensation in affected regions
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a thorough clinical examination by a healthcare professional, who will assess the extent and appearance of the skin. The doctor may perform skin biopsies, blood tests, or cultures to determine underlying causes or rule out infections. Documentation of skin surface involvement (50-59%) is critical to confirm the ICD-10 coding. Additional tests may be ordered to identify any precipitating factors or underlying conditions associated with the skin reaction.
Treatment Protocols: Treatment focuses on managing symptoms, preventing complications, and addressing the underlying cause. Approaches include: - Supportive skin care to keep the skin moist and prevent further peeling - Pain management with appropriate medications - Systemic or topical corticosteroids to reduce inflammation - Antibiotics if infections occur - Discontinuation of triggering medications or addressing causative factors - Hospitalization in severe cases for intensive care and specialized treatment It is important to follow medical guidance strictly for the best outcomes and to reduce the risk of complications.
Clinical Advice & FAQs
Billing Guidance
Is L49.5 a billable ICD-10 code?
Yes, L49.5 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report L49.5?
Clinical documentation must specify the nature of Exfoliation due to erythematous condition involving 50-59 percent of body surface and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
